Daniel Spiegelman
2019
Compensation breakdown
| Non-Equity Incentive Plan | $600,000 |
|---|---|
| Option Awards | $867,181 |
| Salary | $620,192 |
| Stock Awards | $3,120,022 |
| Other | $32,507 |
| Total | $5,239,902 |
Spiegelman received $3.1M in stock awards, accounting for 60% of the total pay in 2019.
Spiegelman also received $600K in non-equity incentive plan, $867.2K in option awards, $620.2K in salary and $32.5K in other compensation.
Rankings
In 2019, Daniel Spiegelman's compensation ranked 2,066th out of 13,971 executives tracked by ExecPay. In other words, Spiegelman earned more than 85.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,066 out of 13,971 | 85th |
Division Manufacturing | 752 out of 5,701 | 87th |
Major group Chemicals And Allied Products | 229 out of 2,200 | 90th |
Industry group Drugs | 185 out of 1,886 | 90th |
Industry Pharmaceutical Preparations | 134 out of 1,398 | 90th |
Pay ratio
| Daniel Spiegelman's Pay | $5,239,902 |
|---|---|
| Median Employee's Pay | $190,917 |
| Pay Ratio | 27to 1 |
In 2019, the annual total compensation of Daniel Spiegelman was $5,239,902.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $190,917.
The ratio of Daniel Spiegelman's pay to the pay of median employee was therefore 27 to one.
Spiegelman's colleagues
We found five more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2019.
2019
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2019
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2019
Robert Baffi
BioMarin Pharmaceutical
President, Global Manufacturing amp; Technical Operations
2019
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2019
Brian Mueller
BioMarin Pharmaceutical